Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 2
2000 6
2001 5
2002 1
2003 1
2004 4
2005 2
2006 6
2007 4
2008 1
2010 4
2012 1
2013 5
2014 3
2015 1
2016 3
2017 2
2018 1
2019 1
2020 4
2021 6
2022 3
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

63 results
Results by year
Filters applied: . Clear all
Page 1
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use.
Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, Černý V, Comin-Colet J, Crespo-Leiro MG, Delgado JF, Édes I, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Fruhwald S, Girardis M, Guarracino F, Harjola VP, Heringlake M, Herpain A, Heunks LMA, Husebye T, Ivancan V, Karason K, Kaul S, Kivikko M, Kubica J, Masip J, Matskeplishvili S, Mebazaa A, Nieminen MS, Oliva F, Papp JG, Parissis J, Parkhomenko A, Põder P, Pölzl G, Reinecke A, Ricksten SE, Riha H, Rudiger A, Sarapohja T, Schwinger RHG, Toller W, Tritapepe L, Tschöpe C, Wikström G, Lewinski DV, Vrtovec B, Pollesello P. Papp Z, et al. Among authors: toller w. J Cardiovasc Pharmacol. 2020 Jul;76(1):4-22. doi: 10.1097/FJC.0000000000000859. J Cardiovasc Pharmacol. 2020. PMID: 32639325 Free PMC article. Review.
Pirfenidone exacerbates Th2-driven vasculopathy in a mouse model of systemic sclerosis-associated interstitial lung disease.
Birnhuber A, Jandl K, Biasin V, Fließer E, Valzano F, Marsh LM, Krolczik C, Olschewski A, Wilhelm J, Toller W, Heinemann A, Olschewski H, Wygrecka M, Kwapiszewska G. Birnhuber A, et al. Among authors: toller w. Eur Respir J. 2022 Oct 20;60(4):2102347. doi: 10.1183/13993003.02347-2021. Print 2022 Oct. Eur Respir J. 2022. PMID: 35332068 Free PMC article.
[Peripartum aortic dissection].
Pachler C, Knez I, Petru E, Dörfler O, Vicenzi M, Toller W. Pachler C, et al. Among authors: toller w. Anaesthesist. 2013 Apr;62(4):293-5. doi: 10.1007/s00101-013-2153-2. Epub 2013 Mar 16. Anaesthesist. 2013. PMID: 23494023 German.
Levosimendan: current status and future prospects.
Archan S, Toller W. Archan S, et al. Among authors: toller w. Curr Opin Anaesthesiol. 2008 Feb;21(1):78-84. doi: 10.1097/ACO.0b013e3282f357a5. Curr Opin Anaesthesiol. 2008. PMID: 18195615 Review.
Perioperative use of levosimendan: best practice in operative settings.
Toller W, Algotsson L, Guarracino F, Hörmann C, Knotzer J, Lehmann A, Rajek A, Salmenperä M, Schirmer U, Tritapepe L, Weis F, Landoni G. Toller W, et al. J Cardiothorac Vasc Anesth. 2013 Apr;27(2):361-6. doi: 10.1053/j.jvca.2012.04.007. Epub 2012 May 30. J Cardiothorac Vasc Anesth. 2013. PMID: 22658687 Review. No abstract available.
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use.
Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, Černý V, Comin-Colet J, Crespo-Leiro MG, Delgado JF, Édes I, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Fruhwald S, Girardis M, Guarracino F, Harjola VP, Heringlake M, Herpain A, Heunks LM, Husebye T, Ivancan V, Karason K, Kaul S, Kivikko M, Kubica J, Masip J, Matskeplishvili S, Mebazaa A, Nieminen MS, Oliva F, Papp JG, Parissis J, Parkhomenko A, Põder P, Pölzl G, Reinecke A, Ricksten SE, Riha H, Rudiger A, Sarapohja T, Schwinger RH, Toller W, Tritapepe L, Tschöpe C, Wikström G, von Lewinski D, Vrtovec B, Pollesello P. Papp Z, et al. Among authors: toller w. Card Fail Rev. 2020 Jul 8;6:e19. doi: 10.15420/cfr.2020.03. eCollection 2020 Mar. Card Fail Rev. 2020. PMID: 32714567 Free PMC article. Review.
An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety.
Heringlake M, Alvarez J, Bettex D, Bouchez S, Fruhwald S, Girardis M, Grossini E, Guarracino F, Herpain A, Toller W, Tritapepe L, Pollesello P. Heringlake M, et al. Among authors: toller w. Expert Rev Cardiovasc Ther. 2021 Apr;19(4):325-335. doi: 10.1080/14779072.2021.1905520. Epub 2021 Apr 2. Expert Rev Cardiovasc Ther. 2021. PMID: 33739204 Review.
Levosimendan, a new inotropic and vasodilator agent.
Toller WG, Stranz C. Toller WG, et al. Anesthesiology. 2006 Mar;104(3):556-69. doi: 10.1097/00000542-200603000-00024. Anesthesiology. 2006. PMID: 16508404 Free article. Review.
63 results